MichaelMLedermanMD

Grant Support

• Case AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
• Defining The Pathogenesis Of Immune Deficiency In Chronic HIV InfectionNational Institute Of Allergy And Infectious Diseases2008–2011
• Bystander Activation Drives T Cell Losses In Chronic HIV InfectionNational Institute Of Allergy And Infectious Diseases2008–2011
• Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
• Developing Rantes Analogues As Topical Strategies To Prevent HIV TransmissionNational Institute Of Allergy And Infectious Diseases2008–2010
• Basic And Comparative Studies Of CCR5 Inhibition To Prevent HIV TransmissionNational Institute Of Allergy And Infectious Diseases2008–2010
• Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2010
• Core--Clinical CoreNational Institute Of Allergy And Infectious Diseases2004–2008
• 2007 Case CFAR Annual Spring ConferenceNational Institute Of Allergy And Infectious Diseases2007
• Topical Immune Modulatory Strategies To Prevent HIV TransmissionNational Institute Of Allergy And Infectious Diseases2006–2007
• Center For AIDS Research(Cfar)National Institute Of Allergy And Infectious Diseases2004–2007
• Case CFAR Meeting: HIV PathogenesisNational Institute Of Allergy And Infectious Diseases2006
• ACTG 5214 Single Dose IL-7 In HIV-1 Subjects Receiving Antiretroviral TreatmentNational Center For Research Resources2006
• Topical Agents To Prevent Mucosal HIV TransmissionNational Institute Of Allergy And Infectious Diseases2002–2006
• Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–2006
• Phase II Study Of Glivic In African Kaposi'S SarcomaNational Institute Of Allergy And Infectious Diseases2005
• Conference On HIV PathogenesisNational Institute Of Allergy And Infectious Diseases2005
• Antiretroviral Outcomes And Resistance In African WomenNational Institute Of Allergy And Infectious Diseases2005
• Immune Mechanisms And HIV Disease PathogenesisNational Institute Of Allergy And Infectious Diseases2004
• ACTG A5147s Lopinavir/Ritonavir VS Gw433908 In HIV-1 PTS With Treatment FailureNational Center For Research Resources2004
• Center For AIDS Research (CFAR)National Institute Of Allergy And Infectious Diseases1999–2003
• Safety &Antiviral Activity Of AMD3100 In HIV-1 InfectionNational Center For Research Resources2000–2002
• ACTG 928--Tnf Receptor On IL6, TNF Alpha, &Immune Markers In HIVNational Center For Research Resources2000–2002
• ACTG 398--Amprenavir/Abacavir/Efavirenz/Adeforvir Dipivoxil In HIV InfectionNational Center For Research Resources2000–2002
• ACTG 384--Protease Inhibitor Or Reverse Transcriptase Inhibitor In HIV InfectionNational Center For Research Resources2000–2002
• ACTG 301: Memantine For AIDS Dementia ComplexNational Center For Research Resources1999–2002
• ACTG 328--Intermittent Recombinant Human Interleukin-2National Center For Research Resources1998–2002
• Core--Clinical ResearchNational Institute Of Allergy And Infectious Diseases1994–2002
• Development Of HIV Coreceptor InhibitorsNational Institute Of Allergy And Infectious Diseases1998–2001
• Viral Activation Transfusion StudyDivision Of Blood Diseases And Resources1995–2000
• Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–1999
• Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Actg--Safety, Tolerability &Antiviral Activity Of Thalidomide In HIVNational Center For Research Resources1997
• AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
• Adult AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1992–1995
• Procysteine TM To Placebo In HIV Infected PTS Taking Antiretroviral NucleosideNational Center For Research Resources1994
• Oral RO 24-7429 (Tat Antagonist) In Patients With HIV InfectionNational Center For Research Resources1994
• Pharmacokinetics Of Oral Procysteine Effects On GlutathioneNational Center For Research Resources1993
• Oral RO 24-7429 (Tat Antagonist) In Patients With HIV InfectionNational Center For Research Resources1993
• IV Procysteine In Patients Infected With Hiv--Effects On Levels Of GlutathioneNational Center For Research Resources1993
• Rifampin, Ciproflaxacin, Clofazimine, Ethambutol, &Amikacin In HIV+ IndividualsNational Center For Research Resources1992–1993
• Procysteine In Patients Infected With Hiv--Effects On Levels Of GlutathioneNational Center For Research Resources1992–1993
• Establishment Of An AIDS Clinical Studies GroupNational Institute Of Allergy And Infectious Diseases1987–1991
• Clinical Trials Study GroupNational Institute Of Allergy And Infectious Diseases1987–1991
• Establishment Of AIDS Clinical Studies GroupNational Institute Of Allergy And Infectious Diseases1990
• Zidovudine For Asymptomatic HIV Infected IndividualsNational Center For Research Resources1990
• Trial Of A Single Dosing Schedule Of Zidovudine In Early AIDS Related ComplexNational Center For Research Resources1990
• Niaid Treatment Regimens For Pneumocystis Carinii In AIDSNational Center For Research Resources1990
• AIDS Study--Fluconazole &Amphotericine-B For Cryptococcal MeningitisNational Center For Research Resources1990
• ACTG Study In Aids--2'3'Dideoxyinosine &Azt For Aids/Arc Patients On AZT TherapyNational Center For Research Resources1990
• Mechanisms Of Cell Loss In HIV InfectionsNational Institute Of Allergy And Infectious Diseases1987–1989